Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute myeloid leukemia.
Usui N, Dobashi N, Asai O, Yano S, Yahagi Y, Saito T, Yamaguchi Y, Kasama K, Okawa Y, Sekiguchi N, Takei Y, Sugiyama K, Ogasawara Y, Ohtsubo H, Kaito K, Kobayashi M. Usui N, et al. Among authors: yahagi y. Int J Hematol. 2002 Dec;76(5):436-45. doi: 10.1007/BF02982809. Int J Hematol. 2002. PMID: 12512838 Clinical Trial.
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
Yano S, Minami J, Nishiwaki K, Shimada T, Dobashi N, Yahagi Y, Takei Y, Takahara S, Ogasawara Y, Sugiyama K, Yamaguchi Y, Saito T, Kasama K, Yokoyama H, Machishima T, Katsube A, Usui N, Aiba K. Yano S, et al. Among authors: yahagi y. Int J Hematol. 2011 Mar;93(3):344-350. doi: 10.1007/s12185-011-0780-4. Epub 2011 Mar 2. Int J Hematol. 2011. PMID: 21365229
[The role of daunorubicin in induction therapy for adult acute myeloid leukemia].
Usui N, Dobashi N, Asai O, Yano S, Kato A, Osawa H, Uno S, Katori M, Nagamine M, Yahagi Y, Yamaguchi Y, Saito T, Kasama K, Takei Y, Ogihara A, Yamazaki H, Kobayashi T, Tajima N, Ogawa M, Kuraishi Y. Usui N, et al. Among authors: yahagi y. Gan To Kagaku Ryoho. 2000 Jul;27(8):1152-9. Gan To Kagaku Ryoho. 2000. PMID: 10945010 Clinical Trial. Japanese.
A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization.
Yano S, Usui N, Dobashi N, Yahagi Y, Takahara S, Sugiyama K, Ogasawara Y, Saito T, Minami J, Kobayashi T, Nikaido T, Takeuchi K, Aiba K. Yano S, et al. Among authors: yahagi y. Ann Hematol. 2009 Jul;88(7):703-4. doi: 10.1007/s00277-008-0653-y. Epub 2008 Dec 4. Ann Hematol. 2009. PMID: 19052745 No abstract available.
Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.
Yamaguchi Y, Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Sugiyama K, Ogasawara Y, Saito T, Minami J, Kobayashi T, Katsube A, Kamiyama Y, Machishima T, Morikawa N, Otsubo H, Kaito K, Asai O, Aiba K. Yamaguchi Y, et al. Among authors: yahagi y. Gan To Kagaku Ryoho. 2009 Jul;36(7):1105-9. Gan To Kagaku Ryoho. 2009. PMID: 19620797
Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.
Yano S, Mori S, Saito T, Yokoyama H, Machishima T, Shimada T, Yahagi Y, Sugiyama K, Ogasawara Y, Takahara S, Kasama K, Katsube A, Kamiyama Y, Suzuki K, Inui Y, Usui N, Aiba K, Yamashita T. Yano S, et al. Among authors: yahagi y. Ann Hematol. 2015 Mar;94(3):491-6. doi: 10.1007/s00277-014-2233-7. Epub 2014 Oct 19. Ann Hematol. 2015. PMID: 25325985 Clinical Trial.
72 results